CAR T-Cell Therapy in Adult Acute Lymphoblastic Leukemia
0 vistas
administrator
06/15/23
The panel of experts shift their discussion to the adult acute lymphoblastic leukemia setting, considering the potential to improve patient outcomes with chimeric antigen receptor (CAR) T-cell therapy.
Mostrar más
Comentarios de Facebook
No se encontraron comentarios